Tyler Zeronda - 02 Oct 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Financial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Issuer symbol
VYNE
Transactions as of
02 Oct 2023
Net transactions value
-$4,163
Form type
4
Filing time
04 Oct 2023, 16:26:12 UTC
Previous filing
05 Jul 2023
Next filing
15 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability $4,163 -1,087 -14% $3.83 6,930 02 Oct 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.